Insider · CIK 0001663758
Marion McCourt
Files at REGN (REGENERON PHARMACEUTICALS, INC.). First filing Nov 5, 2024, latest Sep 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
REGN: REGENERON PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | REGENERON PHARMACEUTICALS, INC. | $2.0M 2,346 shares | -16% | +54% from low0% from high | |
| 3Weak | REGENERON PHARMACEUTICALS, INC. | $845k 1,000 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,215 | $850.00 | $1.0M | 13,134 | 39 d ago |
| Sep 3, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,131 | $857.39 | $970k | 12,003 | 39 d ago |
| Dec 16, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -759 | $730.81 | $555k | 14,230 | Dec 18, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock | +2,332 | $0.00 | $0 | 15,263 | Dec 10, 2024 |
| Dec 9, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -274 | $787.00 | $216k | 14,989 | Dec 10, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +8,981 | $0.00 | $0 | 8,981 | Dec 10, 2024 |
| Nov 1, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +1,000 | $381.40 | $381k | 13,931 | Nov 5, 2024 |
| Nov 1, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,000 | $844.61 | $845k | 12,931 | Nov 5, 2024 |
| Nov 1, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 6,000 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.